These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6284362)

  • 41. [Some aspects of polychemotherapy of acute leukemias].
    Mandelli F; Amadori S; Deriu L; De Rossi G; Isacchi G; Mariani G; Papa G
    Recenti Prog Med; 1971 Mar; 50(3):272-302. PubMed ID: 5285765
    [No Abstract]   [Full Text] [Related]  

  • 42. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The treatment of acute leukemias with methyl-glyoxal-bis (guanylhydrazone) and its combination with 2-hydroxystilbamidine].
    Schwarzenberg L; Schneider M; Cattan A; Amiel JL; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2955-9. PubMed ID: 4292622
    [No Abstract]   [Full Text] [Related]  

  • 44. [Leukemia in children in the Netherlands].
    de Vries JA
    Tijdschr Kindergeneeskd; 1982 Dec; 50(6):177-81. PubMed ID: 6963035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of L-asparaginase in the treatment of leukemia. Experiences from 4 Dutch hospitals].
    Reerink H; Cleton FJ; Elkerbout F; Stenfert Kroese WF
    Ned Tijdschr Geneeskd; 1970 Aug; 114(32):1330-8. PubMed ID: 5270627
    [No Abstract]   [Full Text] [Related]  

  • 46. [Phase II study of THP-adriamycin in acute leukemia].
    Tani Y; Hirayama F; Ogawa K; Mashimoto K; Kubota R; Kanekura J; Oguma S; Veta T; Nakamura H; Shibata M
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2573-4. PubMed ID: 6580842
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of L-asparaginase in the treatment of leukosis].
    Smirnov AN
    Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):62. PubMed ID: 5284456
    [No Abstract]   [Full Text] [Related]  

  • 48. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
    Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of heterologous immune globulins upon human cancer in vivo.
    Sekla B; Holecková E; Janele J; Libánský J; Hnĕvkovský O
    Neoplasma; 1967; 14(6):641-7. PubMed ID: 4169507
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE
    Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602
    [No Abstract]   [Full Text] [Related]  

  • 52. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
    Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
    Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of acute leukemia with 5-azacytidine (NSC-102816).
    McCredie KB; Bodey GP; Burgess MA; Gutterman JU; Rodriguez V; Sullivan MP; Freireich EJ
    Cancer Chemother Rep; 1973; 57(3):319-23. PubMed ID: 4127393
    [No Abstract]   [Full Text] [Related]  

  • 55. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
    Jensen HS; Hansen HH; Dombernowsky P
    Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Vogler WR; Johnson L; Logan T; Raney M
    Cancer Treat Rep; 1983 Nov; 67(11):977-80. PubMed ID: 6580070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prednimustine.
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
    [No Abstract]   [Full Text] [Related]  

  • 58. [Carminomycin in the therapy of leukemias].
    Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
    Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
    Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A statistical survey of leukemia in Ontario and at the Ontario Cancer Foundation Clinics, 1938-1958.
    MacKay EN; Sellers AH
    Can Med Assoc J; 1967 Jun; 96(25):1626-35. PubMed ID: 5229657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.